Health Care/Hospital

SK Biopharmaceuticals Seals 1st Actinium-225-Based Collaborative Research Agreement with Korea Institute of Radiological and Medical Sciences as Steps Toward Becoming Global Radiopharmaceutical Therapy Player

* SK Biopharmaceuticals, Korea Institute of Radiological and Medical Sciences collaborate on discovering and developing radiopharmaceutical drug candidates using analpha-particle emitting radioisotope, actinium-225, for potential cancer treatments * The two sides aim to submit an Investigatio...

2024-11-19 08:00 1491

Celltrion presents additional data from phase III randomized controlled trials to further support biosimilarity for CT-41 (biosimilar candidate of denosumab) and CT-P47 (biosimilar candidate of tocilizumab) at American College of Rheumatology (ACR) Convergence 2024

* 78-Week results from Phase III randomized controlled trial (RCT) including switching data from reference denosumab to CT-P41 (biosimilar candidate of denosumab) demonstrate comparable efficacy and safety results; Results support the therapeutic equivalence of CT-P41 and reference denosumab in...

2024-11-19 02:15 1251

WAT Medical Continues Support for Red Cross and Veterans Association

VANCOUVER, BC, Nov. 18, 2024 /PRNewswire/ -- WAT Medical Enterprise Ltd. proudly reaffirms its commitment to community support by donating to the American Red Cross and the American Veterans Association. These donations are part of the company's pledge to contribute a portion of the proceeds from...

2024-11-18 22:30 834

C Ray Therapeutics Completes Over $100 Million Series A+ Financing, Jointly Led by SCGC and TaiLong Capital

CHENGDU, China, Nov. 18, 2024 /PRNewswire/ -- In November 2024, C Ray Therapeutics (Chengdu) Co., Ltd. (hereinafter referred to as "C Ray"), an innovative enterprise in the field of radiopharmaceuticals, announced the completion of its Series A+ financing round exceeding$100 million. This round ...

2024-11-18 22:00 1341

Lunit Announces Collaboration with AstraZeneca to Develop AI-Powered Digital Pathology Risk Assessment Tools for NSCLC

Collaboration to harness Lunit SCOPE Genotype Predictor for rapid and convenient prediction of non-small cell lung cancer driver mutations SEOUL, South Korea, Nov. 18, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, ...

2024-11-18 22:00 1265

Biosion Announces Exclusive, Global License Agreement with Aclaris Therapeutics on two potential First-in-Class and Best-in-Class Immunology Assets

* Biosion receives over $40 million cash payment as upfront license fee and reimbursement for certain development costs & drug product materials, and 19.9% shares of common stock of Aclaris Therapeutics; additional regulatory and sales milestone payments exceed$900M with tiered single digit sal...

2024-11-18 21:50 1182

Akeso Biopharma to Attend Jefferies London Healthcare Conference and Morgan Stanley 23rd Asia Pacific Summit

HONG KONG, Nov. 18, 2024 /PRNewswire/ -- Akeso Biopharma (9926. HK) ("Akeso" or the "Company") is pleased to announce thatDr. Michelle Xia, the company's founder, chairwoman, president, and CEO, will attend Morgan Stanley's 23rd Asia Pacific Summit.Dr. Bing C. Wang, the company's chief financial ...

2024-11-18 21:16 1041

WELLlife COVID-19/Influenza A&B Home Test on Sale for Black Friday and Cyber Monday

BOLINGBROOK, Ill. , Nov. 18, 2024 /PRNewswire/ -- Stock up your family's medicine cabinet this Black Friday and Cyber Monday. WELLlife, a leading innovator in medical diagnostic and testing solutions, is increasing accessibility to respiratory illness testing in preparation for the year-end holi...

2024-11-18 21:00 725

Bestqool Pro Advanced Series: Revolutionizing Red Light Therapy This Black Friday

NEW YORK, Nov. 18, 2024 /PRNewswire/ -- With winter just around the corner, Bestqool is proud to offer a head start on wellness with their advanced Pro Series , featuring next-level red light therapy suitable ...

2024-11-18 21:00 814

TenNor Announces Positive Topline Results from Rifasutenizol Phase III Trial for H. pylori Infection

SUZHOU, China, Nov 18, 2024 /PRNewswire/ -- TenNor Therapeutics, a clinical-stage company dedicated to developing novel therapies to address unmet needs in infectious diseases, announced today the successful completion of a phase III clinical trial of rifasutenizol (TNP-2198) for the treatment of...

2024-11-18 19:00 963

FDA Grants Breakthrough Therapy Designation to Huahui Health's Libevitug (HH-003) for treatment of chronic Hepatitis D virus infection

BEIJING, Nov. 18, 2024 /PRNewswire/ -- Huahui Health, a clinical-stage biotechnology company focused on discovering and developing novel therapies in the areas of viral hepatitis, hepatology, and oncology, today announced that its investigational hepatitis D and B drug candidate, Libevitug (HH-00...

2024-11-18 18:40 942

SoniVie Ltd., Appoints Veteran Medtech Executive Raymond W. Cohen as Chairman of its Board of Directors

TEL AVIV, Israel, Nov. 14, 2024 /PRNewswire/ -- SoniVie Ltd. , a medical device company developing a proprietary renal denervation system to treat hypertension, announced today the appointment ofRaymond W. Cohen to serve as its chairman of the board of directors. Mr. Coh...

2024-11-18 08:00 777

DermRays Black Friday Event Offers Year's Biggest Savings and Industry Recognition

PLEASANTON, Calif., Nov. 16, 2024 /PRNewswire/ -- This Black Friday, DermRays is excited to announce its most significant sale of the year, offering$130 off sitewide fromNovember 16-30th, 2024. With this limited-time discount, customers can experience the brand's advanced home laser hair removal ...

2024-11-16 21:00 1085

World-Class Scientists Gather at Tencent 2024 WE Summit in Chengdu to Share Cutting-Edge Discoveries

Five eminent speakers, including Nobel laureates and the top Chinese physicist Qi-Kun Xue, share groundbreaking insights at theTencent WE Summit in Chengdu. SHENZHEN, China, Nov. 15, 2024 /PRNewswire/ -- On November 3, the 12th Annual Tencent WE Summit took place at the Chengdu Science Fiction Mu...

2024-11-15 22:57 1678

Neurophet Appoints CTO Donghyeon Kim as Co-CEO, Joining Jake Junkil Been in Dual Leadership to Drive Global Growth

- Donghyeon Kim, Co-Founder and CTO of Neurophet, to Take On Dual Role as CEO, Heading Technology and Company Leadership - Aims to Strategically Expand Business and Management Functions for Establishing a Strong Presence in Global Markets SEOUL, South Korea, Nov. 15, 2024 /PRNewswire/ -- Neuroph...

2024-11-15 22:00 1486

Acepodia Announces FDA Clearance of Investigational New Drug Application for ACE1831 in IgG4-Related Disease

* IND clearance paves the way for Acepodia to enter the clinic for the first time with its autoimmune program  * ACE1831 is an allogeneic gamma delta T cell therapy candidate targeting CD20-expressing cells currently being investigated in non-Hodgkin's lymphoma (NHL) * The planned clinical ...

2024-11-15 20:00 1203

Angel Yeast Turns Automation into Opportunity, Ensuring No Job Losses

YICHANG, China, Nov. 15, 2024 /PRNewswire/ -- Angel Yeast has taken a significant step towards modernization and sustainability by automating its packaging line while ensuring no layoffs for its employees. In 2024, with the completion of the intelligent transformation of its packaging workshop, t...

2024-11-15 20:00 1188

Nuvilab: Advancing School Nutrition with AI-Powered Nutrition Coaching, Wins CES 2025 Innovation Award

SEOUL, South Korea, Nov. 15, 2024 /PRNewswire/ -- Nuvilab announced that its innovative AI nutrition coaching solution,NutriTrex, was awarded the CES 2025 Innovation Award in the Digital Health category. This prestigious honor highlights Nuvilab's groundbreaking approach to promoting healthy eati...

2024-11-15 18:31 1271

Ping An Health Launches "Healthy Steps" Initiative to Boost National Health Literacy Through Collaboration

HONG KONG and SHANGHAI, Nov. 14, 2024 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor", "Ping An Health", or "the Company", Stock Code: 1833.HK) launched the "Healthy Steps" National Health Literacy Initiative at the Ping An Finance Center inShanghai. This ...

2024-11-15 11:00 1352

Harbour BioMed Appoints Dr. Raymond Zheng as Chief Business Officer

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Nov. 14, 2024 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immunol...

2024-11-15 09:55 1148
12345 ... 277